NCT02042690 Haplo-identical HSCT Versus Chemotherapy for Adult Acute Lymphoblastic Leukemia Patients Status COMPLETED Phase PHASE3
NCT02010931 Retrospective Analysis of Survival in Adult MRD Positive Acute Lymphoblastic Leukemia Patients Status COMPLETED Phase N/A
NCT02007811 Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination Status UNKNOWN Phase PHASE1/PHASE2
NCT02003612 Historical Data Analysis of Hematological Remission and Survival in Adults With R/R Acute Lymphoblastic Leukemia Status COMPLETED Phase N/A
NCT02003222 Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT01943682 Safety Study of CPX-351 in Children With Relapsed Leukemia or Lymphoma Status COMPLETED Phase PHASE1
NCT01910428 L-asparaginase Encapsulated in Red Blood Cells (Eryaspase) for Treatment of Adult Patients With ALL or LBL Status TERMINATED Phase PHASE1
NCT01906671 Study on Two Different Formulations of 6-mercaptopurine. Tablet Versus Oral Liquid Status UNKNOWN Phase PHASE4
NCT01886651 The Influence of Thiopurine Methyltransferase Activity on Toxicity After High-dose Methotrexate in Childhood Acute Lymphoblastic Leukemia Status COMPLETED Phase N/A
NCT01873807 HD-Idarubicin/Etoposide Intensified Conditioning Regimen Allo-HSCT for Adult ALL Status UNKNOWN Phase PHASE4
NCT01854567 P3 Study of Umbilical Cord Blood Cells Expanded With MPCs for Transplantation in Patients With Hematologic Malignancies Status COMPLETED Phase PHASE3
NCT01842672 Mitoxantrone and Clofarabine for Treatment of Recurrent NHL or Acute Leukemia Status COMPLETED Phase PHASE1/PHASE2
NCT01810120 Trial to Assess the Efficacy of a TCR Alfa Beta Depleted Graft in Pediatric Affected by ALL or AML and Receiving an HSCT Status COMPLETED Phase PHASE1/PHASE2
NCT01795378 Safety and Efficacy Study of Donor Natural Killer Cells Given After Haploidentical Hematopoietic Cell Transplantation Status COMPLETED Phase PHASE1/PHASE2
NCT01794299 Safety and Efficacy of Donor T-lymphocytes Depleted ex Vivo of Host Alloreactive T-cells (ATIR) in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor Status COMPLETED Phase PHASE2
NCT01766804 Effect of Bovine Colostrum on Toxicity and Inflammatory Responses Status COMPLETED Phase NA
NCT01756118 A Phase I, Dose-finding Study of BEZ235 in Adult Patients With Relapsed or Refractory Acute Leukemia Status COMPLETED Phase PHASE1
NCT01744223 Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT01713582 A Dose-finding Study of the Bromodomain (Brd) Inhibitor OTX015/ Birabresib (MK-8628) in Hematologic Malignancies (MK-8628-001) Status COMPLETED Phase PHASE1